GLIMPSE Trademark

Trademark Overview

On Tuesday, February 16, 2021, a trademark application was filed for GLIMPSE with the United States Patent and Trademark Office. The USPTO has given the GLIMPSE trademark a serial number of 90530563. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 6, 2024. This trademark is owned by REGENXBIO Inc.. The GLIMPSE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the field of clinical trials; Medical and scientific research, namely, conducting clinical trials for others; Medical and scientific research, namely, conducting clinical trials, providing medical and scientific research information in the field of clinical trials
glimpse

General Information

Serial Number90530563
Word MarkGLIMPSE
Filing DateTuesday, February 16, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 10, 2021

Trademark Statements

Goods and ServicesProviding medical and scientific research information in the field of clinical trials; Medical and scientific research, namely, conducting clinical trials for others; Medical and scientific research, namely, conducting clinical trials, providing medical and scientific research information in the field of clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 18, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameREGENXBIO Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameREGENXBIO Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events

Event DateEvent Description
Friday, February 19, 2021NEW APPLICATION ENTERED
Tuesday, May 18, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 21, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 21, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 21, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 30, 2021ASSIGNED TO EXAMINER
Wednesday, June 30, 2021ASSIGNED TO EXAMINER
Thursday, July 1, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 21, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 10, 2021PUBLISHED FOR OPPOSITION
Tuesday, August 10, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 5, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 16, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, March 16, 2022SOU EXTENSION 1 FILED
Wednesday, March 16, 2022SOU EXTENSION 1 GRANTED
Friday, March 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 28, 2022SOU EXTENSION 2 FILED
Wednesday, September 28, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, September 28, 2022SOU EXTENSION 2 GRANTED
Friday, September 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 4, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, April 4, 2023SOU EXTENSION 3 FILED
Tuesday, April 4, 2023SOU EXTENSION 3 GRANTED
Thursday, April 6, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, June 17, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, June 17, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, June 17, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 25, 2023SOU EXTENSION 4 FILED
Monday, September 25, 2023SOU TEAS EXTENSION RECEIVED
Monday, September 25, 2023SOU EXTENSION 4 GRANTED
Wednesday, September 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 6, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, May 6, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

glimpse clinical trials research scientific medical conducting namely field providing information